Skip to content

A prospective, multicenter, open-label, randomized controlled study comparing the value of CBI-Amber and WLI during gastric ESD

A prospective, multicenter, open-label, randomized controlled study comparing the value of CBI-Amber and WLI during gastric ESD

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600116522
Enrollment
Unknown
Registered
2026-01-12
Start date
2026-02-01
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early gastric cancer

Interventions

WLI Group:White light was used throughout the process of submucosal dissection of gastric ESD
CBI-Amber Group:CBI-Amber is used throughout the submucosal dissection process of gastric ESD

Sponsors

Nanjing Drum Tower Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Age: 18 - 70 years old; 2. Early gastric mucosal cancer and precancerous lesions are planned to be treated by ESD. 3.The participants were willing to attend and sign the informed consent form;

Exclusion criteria

Exclusion criteria: 1. Previous history of ESD treatment at adjacent lesion sites, gastric surgery, radiotherapy and chemotherapy; 2. Coagulation disorders or the use of anticoagulant and antiplatelet drugs within one week before surgery; 3. Hemoglobin < 80g/l; 4. Pregnant or lactating women; 5. Combined with severe underlying diseases and organ dysfunction; 6.Situations where researchers consider it unsuitable to participate in the study;

Design outcomes

Primary

MeasureTime frame
Dissection time;

Secondary

MeasureTime frame
Visibility score of bleeding points;Dissection speed;

Countries

China

Contacts

Public ContactWang Lei

Nanjing Drum Tower Hospital

asdfghjklpoiu@5779.com+86 25 83106666

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026